More stories

  • in

    Who is Amy Coney Barrett? Trump's anti-abortion supreme court nominee

    Subject to confirmation by the Senate, Amy Coney Barrett will be the youngest justice on the US supreme court, a position from which she will be set to influence American life for decades yet to come.Donald Trump’s nomination of the 48-year-old comes two years after her name surfaced as a possible replacement for the retiring Anthony Kennedy, whose seat was ultimately filled by Brett Kavanaugh after contentious confirmation hearings.Republicans want Barrett confirmed before the presidential election, on 3 November. Democrats lack the power to block her but the process is likely to be no less contentious than that which Kavanaugh survived.To the fore is Barrett’s religious faith, prominently her association with People of Praise, a charismatic Christian group with what is described as an authoritarian internal structure.Arguments from both political factions have been publicly rehearsed: will Barrett’s religious convictions affect her performance as a supreme court justice, or should they have nothing to do with determining her fitness for such an important role?Conservatives argue public questions about religious beliefs should be excluded. Liberals suggest Barrett’s beliefs could overshadow her ability to administer unconflicted jurisprudence on issues such as abortion and contraception, thereby threatening foundational values of religious liberty.Barrett clerked for the late conservative justice Antonin Scalia, who argued that there is no constitutional right to abortion. The gravest threat Barrett poses, according to many on the left, is to Roe v Wade, the 1973 ruling that ensured abortion rights.In 2017, Trump nominated the Louisiana native and Notre Dame Law School graduate to the Chicago-based seventh US circuit court of appeals.Answering a White House questionnaire, the mother of seven – who adopted two children from Haiti – said she admired justice Elena Kagan, an Obama-appointed abortion rights supporter, for bringing “the knowledge and skill she acquired as an academic to the practical resolution of disputes”.But during her confirmation hearing, Democratic senator Dianne Feinstein memorably said Barrett had “a long history of believing that your religious beliefs should prevail” and added”: “The dogma lives loudly in you.”Barrett has said she is a “faithful Catholic” but her religious beliefs do not “bear in the discharge of my duties as a judge”. She has also said legal careers ought not to be seen as means of gaining satisfaction, prestige or money, but rather “as a means to the end of serving God”.People of Praise, the group to which Barrett belongs, emerged out of the revivalist movement of the 1960s, which blended Catholicism and Protestant Pentecostalism. Founded in South Bend, Indiana, in 1971 and with 1,700 members, the group describes itself as a community that “support[s] each other financially and materially and spiritually”.“Our covenant is neither an oath nor a vow, but it is an important personal commitment,” it says on its website. “Members should always follow their consciences, as formed by the light of reason, and by the experience and the teachings of their churches.”There’s nothing particularly extreme about People of Praise – other than women are not given senior positionsWilliam CashOn Saturday William Cash, chairman of the Catholic Herald, told the Guardian members of People of Praise were on “the conservative side of the church and are unlikely to be the sort of progressives who are fanatical about Pope Francis”.“There’s nothing particularly extreme about People of Praise – other than it is very hierarchical and women are not given senior positions,” he said.The former reporter saw questions about Barrett’s Catholicism and the supreme court in the context of the White House race.“Not only is Biden Catholic, albeit in a very liberal way that will alienate many ‘trads’,” Cash said, “but Melania Trump is also a practicing Catholic and has even had a private audience with Pope Francis in Rome, describing it as one of the most important moments of her life. So Melania, Amy Coney Barrett and Biden are from opposite poles of the US Catholic planet.”Former members of People of Praise and religious scholars have described an organization that appears to dominate some members’ everyday lives, in which so-called “heads”, or spiritual advisers, oversee major decisions. Married women count their husbands as their “heads” and members are expected to tithe 5% of their income to the organization.According to a former member, Adrian Reimers, “all one’s decisions and dealings become the concern of one’s ‘head’, and in turn potentially become known to the leadership”.Heidi Schlumpf, a national correspondent for National Catholic Reporter, called the group’s level of secrecy “concerning”.Trump may sense in Barrett’s nomination a last chance to energise religious conservatives in his race for re-election. The president met evangelical leaders at the White House before introducing Barrett to the press.In 2012, as a professor at Notre Dame, Barrett signed a letter attacking a provision of the Affordable Care Act, the healthcare reform known as Obamacare, that forced insurance companies to offer coverage for contraception, a facet of the law later modified for religious institutions.Republican attempts to bring down the ACA have repeatedly fallen short. If Barrett is confirmed before the November election, one of her first cases shortly after it could determine its fate. More

  • in

    Oleandrin: Trump allies pitch extract from poisonous plant to fight Covid

    Allies of Donald Trump have promoted a plant extract called oleandrin to people seeking to ward off Covid-19. The plant the extract is derived from, oleander, is poisonous and there is no proof the compound is either safe or effective to treat or prevent Covid-19, experts say.But unlike other unproven and potentially dangerous Covid-19 “cures” pitched by Donald Trump and his supporters, including the prescription antimalarial hydroxychloroquine, experts fear this compound could easily reach the public as a dietary supplement.“Supplements are like snake oil, in the sense they are not regulated by the FDA,” said Martin Ronis, a professor in Louisiana State University’s department of pharmacology and experimental therapeutics, referring to the US Food and Drug Administration.While pharmaceutical companies must show the FDA drugs are safe before they go to market, dietary supplements are considered “food” in the US and thus must be proven unsafe before they are removed from the market. Because of this regulatory structure, Ronis said it would be possible for the company behind the plant compound – Texas-based Phoenix Biotechnology – to bring the extract to market.“You can essentially make all kinds of apocryphal claims about supplements,” said Ronis. One of Phoenix’s board members is Mike Lindell, a prominent Trump backer, pitchman, and CEO of MyPillow. Lindell chairs Trump’s re-election effort in Minnesota.While Lindell has pitched Phoenix’s plant extract as a coronavirus cure on TV and to the president’s coronavirus taskforce, the company also quietly received $5m in funding from an undisclosed investor, patented its extract for use in Covid-19, and promoted an early study in monkey cells as proof of efficacy – an assertion one of the study’s own authors denies.Lindell told the TV host Greg Kelly, an anchor on the conservative Newsmax network: “I started using it myself and giving it to friends and family who tested positive.”The interview was one of several television appearances about oleandrin and is prominently displayed on the company’s website. “Is he allowed to do that?” Kelly laughed as he asked his other guest, Andrew Whitney, the vice-chairman and fellow director of Phoenix Biotechnology.“Well, I’m doing it as well,” Whitney replied, “and so is everyone else at the company, because we believe in the product, Greg. We know it works.” Phoenix Biotechnology did not respond to an emailed request for an interview.The Washington Post has reported that Whitney has visited Trump in the White House and pitched oleandrin to him.Oleandrin has not been approved to treat any medical disorder. The supplements industry has also opposed introducing oleandrin to the market.“The unanimous opinion is that this is a stupid idea and no one should allow an oleander supplement to get close to their mouth,” ​said Loren Israelsen, president of the United Natural Products Alliance, in a statement to a trade publication.Phoenix Biotechnology has released only one study on oleandrin’s use against Covid-19. The study was published in what is called a “pre-print”, which means it is not peer-reviewed. Two of the authors had a financial stake in Phoenix Biotechnology. The study, called an “in vitro” study, examined oleandrin’s effect on monkey cells in the laboratory.Pharmaceutical companies looking for FDA approval typically take drugs through a long pipeline of testing including in pre-clinical trials, in non-human primates, and then in a series of clinical trials testing for safety and dosing, leading up to a double-blind, placebo-controlled randomized trial for efficacy.If Phoenix sought approval for its product, the pre-print it published would represent a concept for potential study at the very beginning of this pipeline. The median cost of bringing a drug to market is $985m, according to a recent study in the Journal of the American Medical Association. Most new drugs fail.Phoenix has conducted two clinical trials for safety of oleandrin in cancer treatment, but both were small. Phoenix proposed providing oleandrin in what appears to be a liquid, according to its website.Although Whitney said in his interview with Kelly that Phoenix has researched oleandrin for “25 years”, the earliest research related to the company appears to be from 2002. Phoenix was incorporated in 2003, according to a press release.Phoenix received a patent for its extraction process in 2005, and in that time it has sponsored research at several institutions, including University of Texas San Antonio, the MD Anderson Cancer Center and Duke University.The company appears to be moving ahead in its efforts to monetize oleandrin. The “pre-print” was published on 15 July. The company filed for patents in the US on 18 July and earlier in Australia. The American patent was reportedly granted on 29 July, and Phoenix told the US Securities and Exchange Commission it received $5m from a single, unnamed investor on 7 August. More

  • in

    Ady Barkan delivers powerful DNC speech demanding quality healthcare

    Democratic national convention 2020

    Activist who lost his voice because of ALS urged Americans to vote for Joe Biden and called Trump an ‘existential threat’

    Play Video

    0:48

    Activist Ady Barkan delivers powerful speech on protecting US healthcare – video

    Progressive activist Ady Barkan, who has amyotrophic lateral sclerosis (ALS), gave a powerful address at the Democratic national convention on Tuesday endorsing Joe Biden for president, calling Donald Trump an “existential threat” and demanding access to quality healthcare for all Americans.
    Healthcare is expected to be at the top of voters’ minds ahead of the November election, which has been upended by the coronavirus pandemic that has left more than 170,000 people dead, infected more than 5.4 million people and left millions unemployed, leaving many without health insurance.
    “We live in the richest country in history and yet we do not guarantee this most basic human right,” said Barkan. “Everyone living in America should get the healthcare they need regardless of their employment status or ability to pay.”
    Barkan is a prominent advocate of Medicare forAll, a policy promoted by the Vermont senator Bernie Sanders’s plan to establish a universal health insurance system in the US.
    Biden, who was formally nominated as the Democrats’ choice for president during the second night of the convention on Tuesday, campaigned on improving and expanding the Affordable Care Act, or Obamacare, but does not support Medicare for All.
    However, as the coronavirus pandemic and its economic fallout continues to devastate communities, Biden has inched left on healthcare.
    Nonetheless, Barkan, who has lost his voice because of ALS and has previously testified before Congress using eye movements, urged Americans to vote for Biden in order to avoid the “existential threat of another four years of this president”.
    “Even during this terrible crisis, Donald Trump and Republican politicians are trying to take away millions of people’s health insurance,” Barkan said.
    “We must elect Joe Biden. Each of us must be a hero for our communities, for our country, and then, with a compassionate and intelligent president, we must act together and put on his desk a bill that guarantees us all the health care we deserve.”
    In an interview before his speech aired on Tuesday night, Barkan told the New York Times there was “work to do” to “convince Democratic leadership to shift perspective” on healthcare.
    “I support Medicare for All and Joe Biden obviously doesn’t,” he said. “Many Democratic voters agree with me, as evidenced by the overwhelming support in the exit polls during the primaries. And the pandemic and depression have proven how dangerous it is to tie insurance to employment.”
    The Democratic convention, which has been radically scaled back and moved almost entirely online, has repeatedly attempted to promote a message of unity between liberals, progressives, moderates and also Republicans.
    Barkan was diagnosed with ALS in 2016, at 32 years old. He was little known outside of progressive circles until he cornered the former Arizona senator Jeff Flake on a flight from Phoenix to Washington and urged Flake not to vote for the Republicans’ tax plan. Barkan told Flake about his medical condition and said the tax bill threatened crippling cuts to the federal disability program he relied on for coverage.
    Flake ultimately voted for the measure, but the exchange elevated Barkan’s profile. His group, the Center for Popular Democracy, set up the “Be a Hero” campaign to rally Democrats before the midterms. A profile in Politico called Barkan the “most powerful activist in America”.
    “I am hopeful about this country’s future because right now, there is a mass movement of people from all over this country, rising up,” he told the Guardian in 2019.
    “Nurses, doctors, patients, caregivers, family members – we are all insisting that there is a better way to structure our society, a better way to care for one another, a better way to use our precious time together. If we do the work, we will build the better world our families deserve.”

    Topics

    Democratic national convention 2020

    US healthcare

    US elections 2020

    US politics

    Democrats

    Joe Biden

    news

    Share on Facebook

    Share on Twitter

    Share via Email

    Share on LinkedIn

    Share on Pinterest

    Share on WhatsApp

    Share on Messenger

    Reuse this content More

  • in

    Activist Ady Barkan delivers powerful speech on protecting US healthcare – video

    Play Video

    0:48

    Prominent activist Ady Barkan called on voters to act in the forthcoming presidential election to safeguard the future of the US healthcare system.
    ‘Even during this terrible crisis, Donald Trump and Republican politicians are trying to take away millions of people’s health insurance,’ Barkan said on the second night of the Democratic national convention
    Democrats formally nominate Joe Biden for president

    Topics

    Democratic national convention 2020

    US healthcare

    US elections 2020

    US politics

    Democrats More

  • in

    Unions demand US government take charge over 'inexcusable' PPE shortage

    A large coalition of labor unions and climate action groups have petitioned the US health and homeland security departments to take over the manufacture and distribution of personal protective equipment (PPE).The unions, including the AFL-CIO, the Service Employees International Union, the American Federation of Teachers and the Amalgamated Transit Union, represent more than 15 million workers, from nurses to flight attendants to nannies. The administration is required to respond within 15 days.The groups could sue if they do not receive a response.Healthcare and other frontline workers have experienced rolling shortages of gowns, gloves and critical N95 face masks since March, when the Covid-19 pandemic broke the global supply chain for such products. Healthcare workers could make up between 10 and 20% of total Covid-19 infections, the petition said, citing previous health authority estimates.“It’s terrifying to risk your life every day just by going to work. It brings a lot of things into perspective,” said Rick Lucas, the president of the Ohio State University Nurses Organization and a nurse Ohio State University Wexner Medical Center.“I’m not going to give up on protecting my patients, even though it’s clear the federal government has basically given up on protecting us,” he said. “More than 100 of my coworkers have tested positive for the coronavirus, and many of those positive tests were due to occupational exposure because of lack of PPE. This is inexcusable.”Although PPE supplies have rebounded for large hospitals and long-term care homes, supply chains remain fragile, with periodic shortages accompanying surges of Covid-19 cases in the US. At the same time, independent doctor’s offices have struggled to obtain these supplies at all, as distributors allocate limited supplies to the most critical facilities.Health experts and industry leaders have predicted PPE shortages could persist for years without government intervention. They also said there is no end in sight for emergency conservation measures, which have pushed nurses to use the same N95 masks for a week at a time.The petition, drafted by environmental lawyers and signed by unions, calls on the administration to deploy the full powers of the Defense Production Act (DPA) using an emergency rule-making process. The wartime law allows the US to mandate manufacturers fulfill government contracts first, to make masks, gloves, gowns and other equipment to protect workers from Covid-19.Donald Trump delegated DPA powers to health secretary Alex Azar and acting homeland security secretary Chad Wolf in March. The groups claim neither has used the act sufficiently to remedy the gear shortages.The Trump administration abdicated responsibility for the manufacture and distribution or PPE to states, which has exacerbated shortages as states and institutions compete amongst one another.Demand for PPE is expected to grow again in the coming months, with the potential for Covid-19 to surge during winter months, and as some states with active infections try to push schools to return to in-person instruction. More

  • in

    America's PPE shortage could last years without strategic plan, experts warn

    Shortages of personal protective equipment and medical supplies could persist for years without strategic government intervention, officials from healthcare and manufacturing industries have said.Officials said logistical challenges continue seven months after the coronavirus reached the United States, as the flu season approaches and as some state emergency management agencies prepare for a fall surge in Covid-19 cases.Although disarray is not as widespread as it was this spring, hospitals said rolling shortages of supplies range from specialized beds to disposable isolation gowns to thermometers.“A few weeks ago, we were having a very difficult time getting the sanitary wipes. You just couldn’t get them,” said Dr Bernard Klein, chief executive of Providence Holy Cross medical center in Mission Hills near Los Angeles. “We actually had to manufacture our own.”This same dynamic has played out across a number of critical supplies in his hospital. First masks, then isolation gowns, and now a specialized bed that allows nurses to turn Covid-19 patients on their bellies – equipment that helps workers with what can otherwise be a six-person job.“We’ve seen whole families come to our hospital with Covid, and several members hospitalized at the same time,” said Klein. “It’s very, very sad.”Testing supplies ran short as the predominantly Latino community served by Providence Holy Cross was hard-hit by Covid, and even as nearby hospitals could process 15-minute tests.“If we had a more coordinated response with a partnership between the medical field, the government, and the private industry, it would help improve the supply chain to the areas that need it most,” Klein said.Klein said expected to deal with equipment and supply shortages throughout 2021, especially as flu season approaches.“Most people focus on those N95 respirators,” said Carmela Coyle, CEO of the California Hospital Association, an industry group which represents more than 400 hospitals across one of America’s hardest-hit states.She said believed Covid-19-related supply challenges will persist through 2022.“We have been challenged with shortages of isolation gowns, face shields, which you’re now starting to see in public places. Any one piece that’s in shortage or not available creates risk for patients and for healthcare workers,” said Coyle.If there continues to be an upward trajectory of Covid-19 cases, you can see those supply chains breaking down againKim GlasAt the same time, trade associations representing manufacturers said convincing customers to shift to American suppliers had been difficult.“I also have industry that’s working only at 10-20% capacity, who can make PPE in our own backyard, but have no orders.” said Kim Glas, CEO of the National Council of Textile Organizations, whose members make reusable cloth gowns.Manufacturers in her organization have made “hundreds of millions of products”, but without long-term government contracts, many are apprehensive to invest in equipment to drive economics of scale, and eventually needed to lower prices.“If there continues to be an upward trajectory of Covid-19 cases, not just in the US but globally, you can see those supply chains breaking down again,” Glas said. “It is a healthcare security issue.”For the past two decades, personal protective equipment was supplied to healthcare institutions in lean supply chains in the same way toilet paper was to grocery stores. Chains between major manufacturers and end-users were so efficient there was no need to stockpile goods.But in March, the supply chain broke when major Asian PPE exporters embargoed materials or shut down just as demand increased exponentially. Thus, healthcare institutions were in much the same position as regular grocery shoppers, who were trying to buy great quantities of a product they never needed to stockpile before.“I am very concerned about long-term PPE [personal protective equipment] shortages for the foreseeable future,” said Dr Susan R Bailey, the president of the American Medical Association.“There’s no question the situation is better than it was a couple of months ago,” said Bailey. However, many healthcare organizations including her own have struggled to obtain PPE. Bailey practices at a 10-doctor allergy clinic, and was met with a 10,000-mask minimum when they tried to order N95 respirators.“We have not seen evidence of a long-term strategic plan for the manufacture, acquisition and distribution of PPE,” from the government, said Bailey. “The supply chain needs to be strengthened dramatically, and we need less dependence on foreign goods to manufacture our own PPE in the US.”Some products have now come back to be made in the US – though factories are not expected to be able to reach demand until mid-2021.“A lot has been done in the last six months,” said Rousse. “We are largely out of the hole, and we have planted the seeds to render the United States self-sufficient,” said Dave Rousse, president of the Association of Nonwoven Fabrics Industry.In 2019, 850 tons of the material used in disposable masks was made in the US. Around 10,000 tons is expected to be made in 2021, satisfying perhaps 80% of demand. But PPE is a suite of items – including gloves, gowns and face shields – not all of which have seen the same success.“Thermometers are becoming a real issue,” said Cindy Juhas, chief strategy officer of CME, an American healthcare product distributor. “They’re expecting even a problem with needles and syringes for the amount of vaccines they have to make,” she said.Federal government efforts to address the supply chain have largely floundered. The Federal Emergency Management Agency, in charge of the Covid-19 response, told congressional interviewers in June it had “no involvement” in distributing PPE to hotspots.An initiative headed by Donald Trump’s son-in-law Jared Kushner, called Project Airbridge, flew PPE from international suppliers to the US at taxpayer expense, but was phased out. Further, the government has not responded to the AMA’s calls for more distribution data.Arguably, Klein is among the best-placed to weather such disruptions. He is part of a 51-hospital chain with purchasing power, and among the institutions distributors prioritize when selling supplies. But tribulations continue even in hospitals, as shortages have pushed buyers to look directly for manufacturers, often through a swamp of companies which have sprung up overnight.Now distributors are being called upon not just by their traditional customers – hospitals and long-term care homes – but by nearly every segment of society. First responders, schools, clinics and even food businesses are all buying medical equipment now.“There’s going to be lots of other shortages we haven’t even thought about,” said Juhas. More

  • in

    'The hotspot of a hotspot of a hotspot': coronavirus takes heavy toll in south Texas

    Seventy-two death notices sprawled across an entire page of the Monitor newspaper in Hidalgo county recently.The small-print entries, stacked in five tidy columns, didn’t mention Covid-19. But 27 residents of the south Texas community had died from the virus that day, 22 the day before, and 35 the day before that.“I’ve never seen that ever in my life,” recalled John M Kreidler, a local funeral director, whose family has run Kreidler Funeral Home in McAllen for over a century.That was earlier this month, but things have worsened since. The coronavirus pandemic haunts almost everything in this part of the Rio Grande valley, where more than 92% of the almost 900,000 strong population identifies as Hispanic or Latino.Hand-sanitizing machines and big bins with masks and gloves surround shoppers at the regional grocery store. Outside of Nomad Shrine Club, a rundown event space turned drive-thru pop-up, residents join a long line of people in cars in search of a Covid-19 test with rapid results. Even Tex Mex, a gentlemen’s club, has a somber message for patrons: “Clothed Again.”“The Rio Grande Valley has become the hotspot of a hotspot of a hotspot,” said Ivan Melendez, Hidalgo county’s health authority and a practicing clinician. “We’re at the epicenter of the coronavirus in the United States.”Melendez recalled recently encountering a critically ill patient with an alarmingly low pulse. He tried to warn someone, but nurses informed him that a different doctor had already decided not to intervene because they “didn’t expect for [the patient] to survive”.In the United States, where the prevailing mantra for physicians is “do no harm”, that kind of ruthless calculation strikes deep, especially when so many of the lives at stake are medically vulnerable and easily exploited. More